Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DEVINE: New Vancomycin Dosing Method
NCT01427842Phase 2Unknown
- Sponsor
- Canberra Hospital
- Start
- Aug 2011
- Primary completion
- Jul 2012
- Modality
- Cyclic Peptides, Antimicrobial Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vancomycin in bacterial infection, sponsored by Canberra Hospital. Status: unknown.
02
Drugs
vancomycin
03
Conditions
bacterial infection
Beyond the preview
Go deeper on NCT01427842.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01427842.